azintamid

03/01/2011 - "Potential mechanisms that may account for the efficacy of compound azintamide in functional dyspepsia include modulation of visceral sensitivity and/or gastrointestinal motility."
11/01/2008 - "[Efficacy and safety of compound azintamide on dyspepsia symptoms in a multicentre self-controlled trial]."
11/01/2008 - "To investigate the efficacy and safety of compound azintamide on dyspepsia symptoms. "
03/01/2011 - "Combined therapy of compound azintamid and domperidone may lead to bigger improvement in overall efficacy and health related quality of life in patients with functional dyspepsia than use of motility medicine alone. "
03/01/2011 - "To study the efficacy and safety of combined therapy of compound azintamid and domperidone in functional dyspepsia. "

11/01/2008 - "Compound azintamide greatly improved the symptoms of upper abdominal distention, upper abdominal pain or discomfort and anorexia. "

11/01/2008 - "Compound azintamide greatly improved the symptoms of upper abdominal distention, upper abdominal pain or discomfort and anorexia. "

01/01/1983 - "[Azintamid as a therapeutic agent in psoriasis vulgaris - a therapeutic study]."
03/01/1975 - "[Oragallin purum in the treatment of psoriasis vulgaris]."